Industry Investment News
Mainstream advertising platforms have been reluctant to serve a federally illegal industry, in part due to concerns about existing advertisers not wan...
By Vince Sliwoski, Attorney @ Harris Bricken I’ve spoken with a handful of clients recently who are anxious about Oregon’s new cannabis testing requir...
The Pennsylvania Department of Health is again suing Spotlight PA in an attempt to keep information about how patients obtain a medical marijuana card...
Debate on the legalization of marijuana in North Carolina for medical purposes returned on Wednesday to the state Senate, where a very similar measure...
A bill decriminalizing the possession of two ounces, or less, of marijuana received a hearing before a House committee Wednesday but isn’t expected to...
There are murmurs of serious discontent regarding Maryland’s proposed cannabis regulations – HB0556/SB0516 – which had their first readings earlier th...
WITH the fast-growing CBD sector tied up in a regulatory quagmire hundreds of transatlantic industry players face an uncertain future. However, one UK...
PRESS RELEASE Tucson, AZ, February 16h, 2023 – Halo Infusions & Extractions, LLC (Halo Infusions), southern Arizona’s largest cannabis-infused product...
Industry experts anticipate that 2023 will be a year marked by extensive mergers and acquisitions. Cannabis companies that need to sell their cultivat...
By George P. Angelich, Justin A. Kesselman, Patrick Feeney, Matthew R. Bentley Over the last decade, 37 states and 4 territories in the United States ...
RICHMOND, Va. (AP) — In 2021, Virginia became the first Southern state to legalize marijuana, adopting a policy change that allowed adults to possess ...
On Feb. 9, 2022, Canadian cannabis titan Canopy Growth announced its latest round of layoffs and facility shutdowns, including its departure from its ...
By Hilary Bricken, Principal at Harris Bricken Not much thought is given to ancillary CBD liability. Why is that? Probably because the Food and Drug A...
This is Part One where we examine the state of the market, licensing, approvals and sales. Part Two will delve into all things taxes. Stay tuned for P...
France Reports Highly Positive Patient Response To Medical Cannabis Trial, But Results Unlikely To Impact Decision To Legalise - Cannabis Business Exe...